SmarterDividends
NONOF

Novo Nordisk A/S

NONOF

Healthcare · Stock · semiannual payer

$41.77

Undervalued · +77% Add to Portfolio

Forward Yield

4.22%

Annual Dividend

$1.80

Payout Ratio

45%

5-Yr Growth

28.5%

Ex-Date

Aug 14, 2026

Frequency

Semiannual

Summary

As of September 2026, Novo Nordisk A/S (NONOF) yields 4.22% ($1.80 per share annually), with a blended fair-value estimate of $73.77 — +77% upside, so it screens as undervalued. Dividend safety grade: C (58/100). 6 years of dividend growth.

Is NONOF a good dividend stock?

Yes, with caveats

Novo Nordisk A/S (NONOF) pays a semiannual dividend yielding 4.22% ($1.80/yr), with 6 years of growth and a dividend-safety grade of C. It's a solid income payer, but check the caveats below before buying.

Advantages

  • Comfortable payout ratio (45%)
  • Strong 28.5% 5-yr dividend growth

Risks

  • Cut its dividend in 2017
  • Share price is down over the past 5 years

Key Data

Dividend Yield
4.22%
Payout Ratio
45%
Annual Dividend
$1.80
5-Yr Avg Growth
28.5%
Ex-Dividend Date
Aug 14, 2026
Years of Growth
6
Frequency
semiannual
Beta
0.34
Market Cap
$184.5B
P/E Ratio
10.4
5-Yr Total Return
-23%
52-Week Range
$34.00 – $64.75
Dividend Safety
C · 58/100
Ever Cut?
Yes (2017)
NONOF ex-dividend date & scheduleNext ex-date Aug 14, 2026 · full ex-dividend historyView →

Frequently Asked Questions